首页> 外文期刊>Pediatric Pulmonology >Early postnatal dexamethasone influences matrix metalloproteinase-2 and -9, and their tissue inhibitors in the developing rat lung.
【24h】

Early postnatal dexamethasone influences matrix metalloproteinase-2 and -9, and their tissue inhibitors in the developing rat lung.

机译:出生后的早期地塞米松会影响发育中的大鼠肺中的基质金属蛋白酶2和-9及其组织抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

In order to test the hypothesis that early postnatal exposure to dexamethasone (Dex) influences matrix metalloproteinases (MMP)-2 and -9, as well as their tissue inhibitors (TIMP-1 and -2) in the developing rat lung, newborn rats (3 litters/group) were treated with low Dex (0.1 mg/kg/day, IM), high Dex (0.5 mg/kg/day), or equivalent volumes of saline at 5 days postnatal age (P5), P6, and P7. Lung weight and lung MMP and TIMP levels were determined at sacrifice (7 days postinjection, P14; at weaning, P21; and at adolescence, P45, n = 10/group and time). Dex did not adversely affect lung weight or lung MMP-2 levels, which peaked in all groups at P21 and then fell by P45. In contrast, Dex decreased TIMP-2 at all time intervals, but achieved statistical significance only at P45. An imbalance in MMP-2/TIMP-2 ratio was noted at P21, with elevations occurring in the low and high Dex-treated groups. Lung MMP-9 levels remained comparable with controls during low Dex treatment. However, high Dex exposure resulted in elevated lung MMP-9 levels at P21 and P45. Lung TIMP-1 levels increased only with high Dex exposure at P14 and P21, whereas the lung MMP-9/TIMP-1 ratio was elevated at P21 in the high Dex group, and at P45 in both Dex-treated groups. These data provide evidence that early postnatal dexamethasone results in an imbalance between gelatinase-A and -B, and their tissue inhibitors in the developing rat lung. These changes may be responsible, in part, for some of the known maturational effects of steroids on lung structure in the newborn. Pediatr Pulmonol. 2003; 35:456-462.
机译:为了检验假说,出生后早期接触地塞米松(Dex)会影响发育中的大鼠肺,新生大鼠的基质金属蛋白酶(MMP)-2和-9及其组织抑制剂(TIMP-1和-2) 3胎/组)在出生后5天(P5),P6和P7接受低敏捷(0.1 mg / kg /天,IM),高敏捷(0.5 mg / kg /天)或等量的生理盐水处理。在处死时(注射后7天,P14;在断奶时,P21;和在青春期,P45,n = 10 /组和时间)测定肺重量和肺MMP和TIMP水平。 Dex对肺重量或肺MMP-2水平没有不利影响,在所有组中P21达到峰值,然后P45下降。相反,Dex在所有时间间隔均降低TIMP-2,但仅在P45时才达到统计学意义。在P21观察到MMP-2 / TIMP-2比值失衡,低和高Dex治疗组出现升高。低糖治疗期间,肺MMP-9水平仍与对照组相当。但是,高Dex暴露会导致P21和P45的肺MMP-9水平升高。肺TIMP-1水平仅在P14和P21高暴露于Dex的情况下增加,而高Dex组的P21和两个Dex治疗组的P45的肺MMP-9 / TIMP-1比率均升高。这些数据提供了证据,即出生后的早期地塞米松会导致发育中的大鼠肺中的明胶酶-A和-B及其组织抑制剂之间失衡。这些变化可能部分是由于类固醇对新生儿肺结构的某些已知成熟作用所致。小儿科薄荷油。 2003; 35:456-462。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号